N‐acetylcysteine (1200 mg) vs placebo
N‐acetylcysteine (1200 mg) showed no clear difference in adverse effects compared with placebo (low certainty).
- RR 0.92 [0.75, 1.14]1 study · 96 participantsLow
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
N‐acetylcysteine (1200 mg) showed no clear difference in adverse effects compared with placebo (low certainty).
N‐acetylcysteine (1200 mg) may leads to lower frequency of hospitalization compared with placebo (low certainty).
It is very uncertain whether vitamin C 1400 mg plus vitamin E 800 mg changes severity of pain (use of opioid analgesics) compared with placebo (very low certainty).
It is very uncertain whether N‐acetylcysteine (1200 mg) changes frequency of sickle cell‐related complications (acute chest syndrome) compared with placebo (very low certainty).
N‐acetylcysteine (1200 mg) showed no clear difference in haemoglobin status compared with placebo (low certainty).
L‐arginine showed no clear difference in frequency of crisis (monthly crisis) compared with placebo (low certainty).
L‐arginine showed no clear difference in severity of pain (assessed using a 10‐cm visual analogue scale from… compared with placebo (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether L‐arginine changes frequency of hospitalization (number of days in hospital) compared with placebo (very low certainty).
The review found no eligible studies for this question.
L‐arginine showed no clear difference in haemoglobin status (g/dL) compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether omega‐3 changes adverse effects (any adverse effect) compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether omega‐3 changes haemoglobin status compared with placebo (very low certainty).